Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Multiple Myeloma Light Chain Induced Renal Insufficiency

Tundra lists 1 Multiple Myeloma Light Chain Induced Renal Insufficiency clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07585760

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

This study is a single-center, single-arm, open-label, Phase II interventional clinical trial designed to evaluate the efficacy and safety of a CM336 and isatuximab regimen in patients with newly diagnosed multiple myeloma (NDMM) accompanied by renal impairment (\[eGFR\] \< 40 mL/min). Enrolled subjects will receive three consecutive cycles of induction therapy with CM336 in combination with isatuximab.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2026-07-02

Multiple Myeloma (MM)

Multiple Myeloma Light Chain Induced Renal Insufficiency